Author: Jody Chudley, Wealthy Retirement

I encourage you to forward this to anyone you know who invests. For most people, hearing what I’m about to say would make a life-changing difference in the growth of their portfolios.

After 12 years of not buying a single stock for Daily Journal’s (a company he chairs) portfolio, Berkshire Hathaway’s number two man has finally made another move.

It could rise almost 50% by the end of 2022.

Now is not the time to be an aggressive buyer of equities.

Biotech stocks have been millionaire-makers. And to make a huge difference to your wealth, you need to find only a single one.